Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial, Lancet, vol.366, pp.717-725, 2005. ,
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial, The Lancet, vol.376, issue.9753, pp.1647-1657, 2010. ,
DOI : 10.1016/S0140-6736(10)61924-1
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study, The Lancet Infectious Diseases, vol.12, issue.11, pp.851-858, 2012. ,
DOI : 10.1016/S1473-3099(12)70181-0
Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-467, 2009. ,
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/hal-01199794
Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2620, 2008. ,
DOI : 10.1056/NEJMc0805011
Assessment of the management of cases of fever and malaria by general practitioners in the central Highlands of Madagascar, pp.317-322, 2009. ,
Interactions between Artemisinins and other Antimalarial Drugs in Relation to the Cofactor Model-A Unifying Proposal for Drug Action, ChemMedChem, vol.39, issue.12, pp.2204-2226, 2012. ,
DOI : 10.1002/cmdc.201200383
Antimalarial interaction of quinine and quinidine with clarithromycin, Parasitology, vol.17, issue.03, pp.406-413, 2012. ,
DOI : 10.1186/1475-2875-7-S1-S7
Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 1998. ,
DOI : 10.1016/S1368-7646(98)80208-2
Atorvastatin Is 10-Fold More Active In Vitro than Other Statins against Plasmodium falciparum, Antimicrobial Agents and Chemotherapy, vol.51, issue.7, pp.2654-2655, 2007. ,
DOI : 10.1128/AAC.01330-06
Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum Malaria, Antimicrobial Agents and Chemotherapy, vol.53, issue.6, pp.2248-2252, 2009. ,
DOI : 10.1128/AAC.01462-08
Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene, Journal of Antimicrobial Chemotherapy, vol.65, issue.7, pp.1387-1394, 2010. ,
DOI : 10.1093/jac/dkq173
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum, Malaria Journal, vol.9, issue.1, p.139, 2010. ,
DOI : 10.1186/1475-2875-9-139
Atorvastatin as a Potential Antimalarial Drug: In Vitro Synergy in Combinational Therapy with Dihydroartemisinin, Antimicrobial Agents and Chemotherapy, vol.54, issue.2, pp.966-967, 2010. ,
DOI : 10.1128/AAC.01006-09
Validated HPLC???MS???MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma???pharmacokinetic study, Analytical and Bioanalytical Chemistry, vol.35, issue.2, pp.275-285, 2006. ,
DOI : 10.1007/s00216-006-0655-3
Statins Alone Are Ineffective in Cerebral Malaria but Potentiate Artesunate, Antimicrobial Agents and Chemotherapy, vol.52, issue.11, pp.4203-4204, 2008. ,
DOI : 10.1128/AAC.00513-08
Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model, Malaria Journal, vol.11, issue.1, p.13, 2012. ,
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/pasteur-00836498
Pathogenesis of Cerebral Malaria: Recent Experimental Data and Possible Applications for Humans, Clinical Microbiology Reviews, vol.14, issue.4, pp.810-820, 2001. ,
DOI : 10.1128/CMR.14.4.810-820.2001
Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice, BMC Genomics, vol.8, issue.1, p.452, 2007. ,
DOI : 10.1186/1471-2164-8-452
Behavioural and histopathological alterations in mice with cerebral malaria, Neuropathology and Applied Neurobiology, vol.50, issue.2, pp.177-188, 2006. ,
DOI : 10.1136/jnnp.69.4.433
Simvastatin Treatment Shows No Effect on the Incidence of Cerebral Malaria or Parasitemia during Experimental Malaria, Antimicrobial Agents and Chemotherapy, vol.52, issue.4, pp.1583-1584, 2008. ,
DOI : 10.1128/AAC.01428-07
Statins Fail to Improve Outcome in Experimental Cerebral Malaria and Potentiate Toll-Like Receptor-Mediated Cytokine Production by Murine Macrophages, American Journal of Tropical Medicine and Hygiene, vol.81, issue.4, pp.631-637, 2009. ,
DOI : 10.4269/ajtmh.2009.09-0204
Scanning electron microscopy of the neuropathology of murine cerebral malaria, Malaria Journal, vol.5, issue.1, p.116, 2006. ,
DOI : 10.1186/1475-2875-5-116
Retinal Pathology of Pediatric Cerebral Malaria in Malawi, PLoS ONE, vol.160, issue.2, p.4317, 2009. ,
DOI : 10.1371/journal.pone.0004317.t002
Statins Decrease Neuroinflammation and Prevent Cognitive Impairment after Cerebral Malaria, PLoS Pathogens, vol.233, issue.12, p.1003099, 2012. ,
DOI : 10.1371/journal.ppat.1003099.s007
URL : http://doi.org/10.1371/journal.ppat.1003099
Challenges in the Determination of Early Predictors of Cerebral Malaria: Lessons from the Human Disease and the Experimental Murine Models, Neuroimmunomodulation, vol.16, issue.2, pp.134-145, 2009. ,
DOI : 10.1159/000180268
Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria, Trends in Immunology, vol.24, issue.9, pp.491-499, 2003. ,
DOI : 10.1016/S1471-4906(03)00229-1
Plasmodium berghei: Cerebral Malaria in CBA Mice Is Not Clearly Related to Plasma TNF Levels or Intensity of Histopathological Changes, Experimental Parasitology, vol.95, issue.1, pp.1-7, 2000. ,
DOI : 10.1006/expr.2000.4508
Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage, Malaria Journal, vol.10, issue.1, p.52, 2011. ,
DOI : 10.1016/j.exppara.2010.01.005
URL : https://hal.archives-ouvertes.fr/inserm-00663669
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation, Nature Reviews Immunology, vol.116, issue.5, pp.358-370, 2006. ,
DOI : 10.1038/nri1839
Statins and the vascular endothelial inflammatory response, Trends in Immunology, vol.28, issue.2, pp.88-98, 2007. ,
DOI : 10.1016/j.it.2006.12.003
The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria, European Journal of Clinical Pharmacology, vol.41, issue.Suppl 1, pp.1003-1009, 2006. ,
DOI : 10.1007/s00228-006-0203-2
More Intensive Lipid Lowering is Associated with Regression of Coronary Atherosclerosis in Diabetic Patients with Acute Coronary Syndrome ???Sub-Analysis of JAPAN-ACS Study, Journal of Atherosclerosis and Thrombosis, vol.17, issue.10, pp.1096-1107, 2010. ,
DOI : 10.5551/jat.5660
Efficacy and Safety of Lovastatin Therapy in Adolescent Girls With Heterozygous Familial Hypercholesterolemia, PEDIATRICS, vol.116, issue.3, pp.682-688, 2005. ,
DOI : 10.1542/peds.2004-2090
Effects of statin and lipoprotein metabolism in heart failure, Journal of Cardiology, vol.55, issue.3, pp.287-290, 2010. ,
DOI : 10.1016/j.jjcc.2010.02.003
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study, BMJ, vol.337, issue.nov11 1, p.2423, 2008. ,
DOI : 10.1136/bmj.a2423
MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine, Gut, vol.49, issue.4, pp.526-533, 2001. ,
DOI : 10.1136/gut.49.4.526
Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1- infected cornea, Invest Ophthalmol Vis Sci, vol.39, pp.1854-1862, 1998. ,
The ageing systemic milieu negatively regulates neurogenesis and cognitive function, Nature, vol.169, issue.7362, pp.90-94, 2011. ,
DOI : 10.1038/nature10357
The C-C motif chemokine ligands CCL5, CCL11, and CCL24 induce the migration of circulating fibrocytes from patients with severe asthma, Mucosal Immunology, vol.93, issue.4, pp.718-724, 2013. ,
DOI : 10.1111/j.1582-4934.2011.01344.x
Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice, Journal of Clinical Investigation, vol.122, issue.3, pp.974-986, 2012. ,
DOI : 10.1172/JCI60588DS1
In Vivo Processing of CXCL5 (LIX) by Matrix Metalloproteinase (MMP)-2 and MMP-9 Promotes Early Neutrophil Recruitment in IL-1??-Induced Peritonitis, The Journal of Immunology, vol.190, issue.1, pp.401-410, 2013. ,
DOI : 10.4049/jimmunol.1202286
Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma, Hepatology, vol.16, issue.6, pp.2242-2254, 2012. ,
DOI : 10.1002/hep.25907
Cerebral malaria protection in mice by species-specific Plasmodium coinfection is associated with reduced CC chemokine levels in the brain, Parasite Immunology, vol.36, issue.11, pp.637-641, 2011. ,
DOI : 10.1111/j.1365-3024.2011.01329.x
Leishmania major Modulates Chemokine and Chemokine Receptor Expression by Dendritic Cells and Affects Their Migratory Capacity, Infection and Immunity, vol.73, issue.4, pp.2564-2567, 2005. ,
DOI : 10.1128/IAI.73.4.2564-2567.2005
Plasmodium berghei ANKA infection in ICR mice as a model of cerebral malaria, Iran J Parasitol, vol.7, pp.62-74, 2012. ,
IFN-??-Producing CD4+ T Cells Promote Experimental Cerebral Malaria by Modulating CD8+ T Cell Accumulation within the Brain, The Journal of Immunology, vol.189, issue.2, pp.968-979, 2012. ,
DOI : 10.4049/jimmunol.1200688
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo, Atherosclerosis, vol.189, issue.2, pp.408-413, 2006. ,
DOI : 10.1016/j.atherosclerosis.2005.12.022
Statins and sepsis: multiple modifications at multiple levels, The Lancet Infectious Diseases, vol.7, issue.5, pp.358-368, 2007. ,
DOI : 10.1016/S1473-3099(07)70111-1
CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria, Disease Markers, vol.30, issue.1, pp.439-488, 2011. ,
DOI : 10.1155/2011/828256
Plasmodium berghei ANKA infection increases Foxp3, IL-10 and IL-2 in CXCL-10 deficient C57BL/6 mice, Malaria Journal, vol.10, issue.1, p.69, 2011. ,
DOI : 10.1158/1078-0432.CCR-06-1417
Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria, The Lancet, vol.351, issue.9118, pp.1768-1772, 1998. ,
DOI : 10.1016/S0140-6736(97)09439-7
Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain, International Immunology, vol.15, issue.5, pp.633-640, 2003. ,
DOI : 10.1093/intimm/dxg065
Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol, Malaria Journal, vol.9, issue.1, p.85, 2010. ,
DOI : 10.1186/1475-2875-9-85
Clinical review: severe malaria, Critical Care, vol.7, issue.4, pp.315-323, 2003. ,
DOI : 10.1186/cc2183
Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.4, pp.476-481, 2005. ,
DOI : 10.1136/jnnp.2004.043893
Cognitive Impairment After Cerebral Malaria in Children: A Prospective Study, PEDIATRICS, vol.119, issue.2, pp.360-366, 2007. ,
DOI : 10.1542/peds.2006-2027